RepliCel Life Sciences Inc (TSXV:RP)
RepliCel is a regenerative medicine company developing autologous cell therapies that address diseases caused by a deficit of healthy cells required for normal healing and function.
Allergan Plc is considering options for its women’s health unit, Bloomberg reported on Monday, citing people with knowledge of the matter.
A sale, which would likely attract interest from private equity firms, could value the business at more than $5 billion, according to the Bloomberg report. (https://bloom.bg/2pYuzK9)
Allergan did not immediately respond to a request for comment.
Source: CNBC
